Home

Are you ready?

At Kisaco Research we bring our clients both intensively researched conference programmes and the most influential networks. Kisaco Research genuinely helps its clients set and reset their business destinations and chart their own courses.

Kisaco Portfolios

Our level of research ensures the topics and products we offer are of utmost relevance and timeliness; our 30+ years of combined experience in the event industry means we have an unmatched level of strategic social engineering onsite.

Events

Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively. Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Our platforms are neutral, so that our attendees get the right information from the most relevant people.

There is no doubt that the future of beauty is personalized.The consumer is moving away from the ‘one size fits all’ approach, preferring to embrace products and services tailored to their individual needs and unique lifestyle.As new data transpires, the role of biomarkers and environmental factors in an individual’s response to cosmetic ingredients becomes clear. Combined with modern technological advances from smart diagnostic devices to self-learning algorithms, which enable large scale data collection and analysis, personalization has the potential to completely revolutionize the beauty and personal care industry. The Personalized Beauty Summit brings together leaders from both the technology and cosmetics industry, to showcase cutting edge research and new technological advances whilst exploring key trends and consumer priorities.Join the event to hear more about how to expand your current portfolio, foster consumer engagement and brand loyalty with data-driven product recommendations and experiences, whilst also balancing profitability, scalability and supply chain flexibility.The future of beauty is personalized.

Animal Health Investment Europe is a premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners. To complement our investment pitches, we host CEO-level discussions that address the trends and market dynamics of the animal health industry, across all species. A key element of the investment forum is the full use of a our 1-on-1 private meeting platform, available to all attendees. Going forward, as the industry experiences a shift towards the detection and prevention of disease, we are increasingly focused on presenting innovation in nutritional health, data analytics, sensors and diagnostics.This year, for the first time, we will be categorising our presenting companies according to the level of investment they’re seeking, early, mid and late stage.

“In 2050 the world will require 100% more food and 70% of this must come from efficiency improvements.” - International Feed Industry FederationFollowing recent bans and restrictions on the use of antibiotic growth promotors in animal feed in both the E.U. and the U.S., a huge movement to find their alternatives has begun. With evidence emerging to support the beneficial effects of microbiome manipulation through prebiotics, probiotics, and other alternative strategies, it is more important than ever to form collaborations to explore how to translate research into commercially viable products, to promote health and improve feed efficiency of livestock animals.“International feed tonnage has exceeded 1 billion metric tons for the second consecutive year, with a total of 1.07 billion metric tons of feed produced in 2017” - The 2018 Alltech Global Feed SurveyThe Animal Microbiome Congress will bring together leading experts including veterinary researchers, animal producers, food retailers, feed and strain manufacturers and animal nutrition and pharmaceutical companies, to showcase unpublished and translatable research, changing consumer priorities, and evidence-based case studies from emerging biotech companies.

Our speakers will explore ground-breaking developments surrounding CRISPR and utilising all genome editing tools as a therapy. It will focus on advancements to overcome ‘off targets’, delivery approaches for in vivo applications and efficacy considerations across patient diversity.CRISPR Therapeutics’ TJ Cradick and Cellectis’ Stefan Scherer will share their clinical trial experiences within therapeutic genome editing applicationsHarvard’s Richard Sherwood will share how to improve CRISPR safety by utilizing machine learningCasebia’s Abraham Scaria will offer delivery guidance to progress in vivo applicationsIn an extremely busy and exciting space it can be hard to pick out the top tool innovations to increase precision and properly discuss clinical challenges, this meeting will facilitate this. It will provide an opportunity with engage with the leading experts who are working on new platforms, leading the clinical trials and have patient insights. It is also a forum to build collaborations to create a clinically and commercially viable, effective and safe approach within gene and cell therapy medicine. ‘CRISPR medicines have the potential to transform the treatment for rare genetic and perhaps common diseases; the challenge for scientists is to demonstrate that these medicines can be both safe and effective’ – Steve Rees, VP of Discovery Biology, AstraZenecaSPEAKERS FROM

The Autonomous Vehicle Hardware Summit is the first and only conference focusing solely on architectural and engineering challenges for silicon, sensors and systems in autonomous vehicles. The automotive electronics industry will grow to $280 billion by 2020, and will likely look very different, as new entrants such as NVIDIA enter the space with new autonomous driving solutions and advanced-node AI accelerators. Many new entrants have little to no experience of the automotive industry’s stringent functional safety requirements, while testing and simulation methodologies for semiconductor products are meeting with skepticism from auto OEMs and their suppliers.To control the automated driving value chain a knowledge of hardware is crucial – the hardware architectures of Level 3, 4 & 5 AVs, often termed ‘super computers on wheels’, will be fundamental to the ultimate effectiveness and cost of the vehicle, and the overall quality of the user experience. The AV Hardware Summit will bring together 150+ tech and auto leaders to help overcome these challenges and pave the way for the next generation of driverless cars.

Join the first ever conference connecting human biotechs with the animal health industry.
Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.

The animal health industry is changing. Since the Zoetis spin-out from Pfizer we’ve seen further companies such as Elanco follow suit with successful IPO’s.Investors are beginning to take notice, however questions still remain regarding the opportunities in the industry: - What does animal health really offer investors when compared to human health? - In what ways can human biotech’s leverage the space to maximize their own technology?Our investor conference in Boston will answer these questions and bring together domain experts and market leading companies to present the current trends and dynamics of the animal health industry and to outline where capital investment can make an impact.

The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.

The volume of biological data available to drug companies today requires increasingly sophisticated tools for storage, sharing and analysis. Machine learning, cloud, data commons and quantum computing all offer important discovery prospects for in silico units. But they also present problems such as build vs buy debate, overcoming cultural differences between biologists and data scientists, standardization and interoperability challenges.At the Bioinformatics Infrastructure Congress where IT and computational biology heads from pharma, biotech and academia explore how to implement new tools and optimize data storage, security, visualization and analysis. Explore in silico discovery infrastructure and best practice data management for life science and healthcare professionals, including a full day on AI and machine learning. Leave with actionable ideas to improve data management infrastructure, relationships with the best tool providers on the market and insight into how to implement advanced analytics into drug discovery and development.

The cloud has rapidly grown from being a market disrupter to an essential IT strategy for enterprise. 77% of businesses have at least one application or portion of their enterprise IT infrastructure in the cloud. Migrating to the cloud is tough. Whether you are fully cloud-native, in a hybrid cloud environment or just taking the first steps, The Cloud Migration Summit will debunk migration myths and help IT Strategists and I&O leaders properly foster a corporate cloud culture and avoid migration pitfalls that might ramp up expenses bureaucracy and hamper digital transformation efforts. Discover how the cloud front runners and industry leaders accelerated their digital transformations through a series of dedicated case studies, panel discussions and round tables.83% of IT workloads will be in the cloud by 2020. Don't get left behind the curve.

“Targeted protein degradation promises to be the greatest innovation in small molecule drug discovery in the new millennium.” - Manfred Koegl, Lab Head Oncology Research, Boehringer IngelheimWith capital investment coming in fast, industry is ready to commercialise the therapeutic potential of PROTACs and molecular glues to build safe, effective targeted protein degradation products. As Arvinas conducts the groundbreaking first PROTAC clinical trials this year, it could be only be a matter of time before PROTACs and molecular glues enter the market. The European Protein Degradation Congress will bring together leading industry players within big pharma and biotech along with expert academics in the ubiquitin space - providing an open forum and facilitate the sharing of in vitro and in vivo data, as well as build a deeper mechanistic understanding of the ubiquitin pathways and techniques to make the ‘undruggable’ druggable.Expect to hear strategies to overcome the structural biology, pharmacology and chemistry obstacles associated with the discovery and development of these bi-functional and single entity molecules.

Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors and multinational nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.

“Skin microbiome today is exploding with companies all over the world. Now we’re at a point where the awareness is so great that there’s almost like a tidal wave of interest in microbiome!” - Mike Conti, Solabia2018 saw the microbiome move to the forefront of over 300 industry leaders, who came together to exchange ideas at our Global Skin Microbiome Congress Series, the first dedicated congress focusing solely on Skin Microbiome.With the microbiome set to be the biggest trend in skincare for 2019, we are incredibly excited to bring our flagship congress back to Boston, building on our success globally and connecting over 300 industry leaders.This year, we take a deep-dive into the two key areas critical for success in this in this evolving field, with our 2 concurrent tracks of content. Track 1 will focus on developing a functional understanding of the microbiome, whereas track 2 will be focusing on builing a commercial viable business.Don't miss the opportunity to join leading industry experts to explore next steps for skin microbiome research and development, as well as commercialization. The inaugural Skin Microbiome Congress in 2018 SOLD OUT, don't miss your chance to attend this year's event!

The AI Hardware Summit is the first and only conference dedicated solely to the ecosystem developing hardware accelerators for neural networks and computer vision.Join 200+ senior technology leaders from AI chip start-ups, semiconductor companies, system vendors/OEMs, data centers, end users, financial services, investors and fund managers, to build a comprehensive architectural roadmap of the emerging AI chip market.Take advantage of unique networking opportunities to meet key industry leaders 1-2-1, whilst also exploring: Innovations and Optimizations of High-Performance Chip Architectures: GPUs, ASICs & TPUs, FPGAs…Alternative Approaches: hybrid digital/analog computing, neuromorphics & neuromemristive systems, quantum computing.The Role of Software: assistance software, software frameworks, ecosystems, and applications. Generating user-friendly native code and linking open source machine learning frameworks like TensorFlow & Caffe.Industry Developments: Start-up & Corporate R&D, Venture Capital and Corporate Venture Capital investment trends, strategic acquisitions & partnerships.Forecasts predict that the AI (chipsets) market is expected to grow from USD 7.06 Billion in 2018 to USD 59.26 Billion by 2025, at a CAGR of 35.5% from 2018 to 2025 (Business Wire, 2018), the chip market is no longer standing still. As we approach a paradigm shift in computing, there is little doubt that a combination of the processing units currently in development will accelerate AI research and development, far beyond the capabilities of current platforms. There is need for sharing knowledge on the best way to turn this shift into an opportunity and roadmap the future ahead.

The Global Probiotics in Animal Feed Market is poised to grow at a CAGR of around 7.9% over the next decade to reach approximately $6.37 billion by 2025.The European Animal Microbiome Congress brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, animal pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to showcase the latest commercially viable research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering. Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. This conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts.

Showcasing the Most Exciting Innovation in Farm Management, Nutrition and Health InnovationNow in its 3rd year, the Aquaculture Innovation Summit is a major part of the Animal Health Innovation series, which focuses on showcasing and supporting innovation and sustainability initiatives in three key areas of aquaculture: farm management, nutrition and health.Our objective at this two-day event is to bring to light cutting-edge modern technologies and solutions that are helping shape one of the most important industries for the future of global protein. Below is a preview of some of the topics to be discussed:Innovation Showcase: The 12 most exciting innovations in aqua across farm management, nutrition and health, each seeking financial investment and strategic partnershipDigital Trends: How innovative companies are using digital and tech solutions to prevent diseaseTech & Productivity: What challenges are seafood producers currently facing and what technology can make an impact on productivity?Health and Nutrition Trends: Oral Vaccines, Medicated Feed Additives and Fish MicrobiomeGlobal Focus: Trends in the aquaculture markets in Latin America and Asia.Expanded focus on species: What are the opportunities for innovation in Tilapia and Shrimp?

The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.View highlights from the inaugural Skin Microbiome Congress, May 30-31, 2018Join 200+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

The inaugural AI Hardware Summit sold out in 2018 and is the first and only conference dedicated solely to the ecosystem developing hardware accelerators for neural networks and computer vision.Join 600+ senior technology leaders from AI chip start-ups, semiconductor companies, system vendors/OEMs, data centers, end users, financial services, investors and fund managers, to build a comprehensive architectural roadmap of the emerging AI chip market.Take advantage of unique networking opportunities to meet key industry leaders 1-2-1, whilst also exploring: Innovations and Optimizations of High-Performance Chip Architectures: GPUs, ASICs & TPUs, FPGAs…Alternative Approaches: hybrid digital/analog computing, neuromorphics & neuromemristive systems, quantum computing.The Role of Software: assistance software, software frameworks, ecosystems, and applications. Generating user-friendly native code and linking open source machine learning frameworks like TensorFlow & Caffe.Industry Developments: Start-up & Corporate R&D, Venture Capital and Corporate Venture Capital investment trends, strategic acquisitions & partnerships.Forecasts predict that the AI (chipsets) market is expected to grow from USD 7.06 Billion in 2018 to USD 59.26 Billion by 2025, at a CAGR of 35.5% from 2018 to 2025 (Business Wire, 2018), the chip market is no longer standing still. As we approach a paradigm shift in computing, there is little doubt that a combination of the processing units currently in development will accelerate AI research and development, far beyond the capabilities of current platforms. There is need for sharing knowledge on the best way to turn this shift into an opportunity and roadmap the future ahead.

The Phage Futures Congress will bring together peers from biotech companies and academia, along with experts from regulatory bodies, pharmaceutical companies and government institutions, to discuss how to actively progress clinical science and viable phage application routes to market. "This congress has the potential to act as a catalyst to further cooperative and collaborative efforts to develop alternate Phage based approaches to the antibiotic crisis." - Carl Merril, Adaptive Phage Therapeutics

There is no doubt that the future of beauty is personalised.The consumer is moving away from the ‘one size fits all’ approach, preferring to embrace products and services tailored to their individual needs and unique lifestyle.As new data transpires, the role of biomarkers and environmental factors in an individual’s response to cosmetic ingredients becomes clear. Combined with modern technological advances from smart diagnostic devices to self-learning algorithms, which enable large scale data collection and analysis, personalisation has the potential to completely revolutionise the beauty and personal care industry. The Personalised Beauty Summit brings together leaders from both the technology and cosmetics industry, to showcase cutting edge research and new technological advances whilst exploring key trends and consumer priorities.Join the event to hear more about how to expand your current portfolio, foster consumer engagement and brand loyalty with data-driven product recommendations and experiences, whilst also balancing profitability, scalability and supply chain flexibility.The future of beauty is personalised.

Animal Health Innovation Asia is a premier B2B conference showcasing emerging Animal Health and Nutrition companies, from Japan and across Asia-Pacific, that are actively seeking financial investment or strategic partnership conversations with large corporate firms.Our plenary sessions provide guidance on veterinary market trends and animal health industry dynamics in Japan & APAC, insight on how emerging companies are using new innovations to prevent disease and market analysis on the M&A activity across the animal health and nutrition markets in Asia.

SKIN MICROBIOME IS SET TO REVOLUTIONISE DERMATOLOGYWith the European cosmetics industry playing a leading role in science-driven product development and innovation in skincare, we are proud to announce that we are bringing the Skin Microbiome Congress to London, following the success of our sold out inaugural event in Boston.As new clinical data transpires to support the role of the skin microbiome in common conditions from acne and eczema to dandruff and skin allergies, Pharmaceutical Researchers and Cosmetic Formulators alike are turning their attention to designing and testing products that contain live bacteria, bacterial extracts or prebiotic and postbiotic ingredients to manipulate the skins microbiota.The European Skin Microbiome Congress will bring together leaders from pharmaceutical, therapeutics and cosmetics industries, to showcase:• Cutting edge research• New therapeutic & cosmetic advances• Consumer trends & insights• Regulatory considerationsJoin 200+ industry leaders to explore the different pathways market and how to translate therapeutic research into commercially viable cosmetic products.View highlights from the inaugural SOLD OUT Skin Microbiome Congress, May 30-31, 2018Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.

Personalised Nutrition Europe is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet, incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.Personalised Nutrition Europe draws on industry leaders who discuss how to integrate existing and new types of data around health and disease to reveal informative and actionable insights. Last Year's Key Takaways:How can I scale up my product?How can I measure the performance of my nutritional intervention?How can I better target the consumer by understanding motivation behind nutrition choices?How can I partner with retailers and industry leaders?How do I use my data to forge partnerships in industry?How can I target my consumer better and ensure they adhere to nutritional plans?How to identify and incorporate the best science into my business?How can I produce high quality data with low cost testing?How can I improve my business strategy to capitalise on growing interest in personalisation?What policy changes do I need to consider to protect my business?The event dates currently listed are subject to change.

Data has gravity.It is well known that the network edge, in the Internet of Things, is where the critical mass of digital data resides, and where it is collected. Scalability bottlenecks to ubiquitous AI, such as power consumption, bandwidth, latency, connectivity and security have led to recent innovations in on-device processing and edge infrastructure such as micro-data centers and distributed computing architecture.The Edge Computing market will reach $34 billion by 2023, growing at 35% annually, unleashing a wave of services and applications at the network edge that can be optimized with artificial intelligence. As a recent explosion in hardware innovation provides the necessary compute to migrate diverse AI workloads to the Edge, a new generation of edge-native and edge-enhanced software applications is emerging.The Edge AI Summit will bring together 200+ key thought-leaders and industrial practitioners to discuss the challenges and opportunities of decentralized, distributed intelligence. Join us to examine use cases of edge-based artificial intelligence applications and explore this new computing paradigm that promises to accelerate and democratize AI adoption across the globe. This event is intended for Senior Director/VP-level attendees and above, and is a high-level networking and business development meeting, with content tracks focusing on both business and technology.

The Phage Futures Congress will bring together peers from biotech companies and academia, along with experts from regulatory bodies, pharmaceutical companies and government institutions, to discuss how to actively progress clinical science and viable phage application routes to market. "This congress has the potential to act as a catalyst to further cooperative and collaborative efforts to develop alternate Phage based approaches to the antibiotic crisis." - Carl Merril, Adaptive Phage Therapeutics

CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. 2019 has seen yet another approval added to the list with NICE’s recommendation for Kymriah for diffuse large B-cell lymphoma. With emerging research to support the development of safe and efficacious CAR-Ts , the race is now on to lead the commercialization of accessible therapies.The European CAR-T congress is bringing together the leading pharmaceutical companies, the disruptive biotechs and pioneering academic institutions to assess emerging novel data and tackle the current challenges including antigen discovery, manufacturing scalability and efficacy in order to increase the uptake of CAR-T therapy.

Welcome to the 5th Annual North America Microbiome Congress!The North America Microbiome Congress, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.

Animal Health Investment Europe is a premier investment forum showcasing the most exciting investment opportunities in animal health and nutrition and connecting those businesses with financial investors and strategic corporate partners. To complement our investment pitches, we host CEO-level discussions that address the trends and market dynamics of the animal health industry, across all species. A key element of the investment forum is the full use of a our 1-on-1 private meeting platform, available to all attendees. Going forward, as the industry experiences a shift towards the detection and prevention of disease, we are increasingly focused on presenting innovation in nutritional health, data analytics, sensors and diagnostics.This year, for the first time, we will be categorising our presenting companies according to the level of investment they’re seeking, early, mid and late stage.

There is no doubt that the future of beauty is personalized.The consumer is moving away from the ‘one size fits all’ approach, preferring to embrace products and services tailored to their individual needs and unique lifestyle.As new data transpires, the role of biomarkers and environmental factors in an individual’s response to cosmetic ingredients becomes clear. Combined with modern technological advances from smart diagnostic devices to self-learning algorithms, which enable large scale data collection and analysis, personalization has the potential to completely revolutionize the beauty and personal care industry. The Personalized Beauty Summit brings together leaders from both the technology and cosmetics industry, to showcase cutting edge research and new technological advances whilst exploring key trends and consumer priorities.Join the event to hear more about how to expand your current portfolio, foster consumer engagement and brand loyalty with data-driven product recommendations and experiences, whilst also balancing profitability, scalability and supply chain flexibility.The future of beauty is personalized.

Welcome to the 4th Annual North America Microbiome Congress!The 4th Annual North America Microbiome Congress in Washington DC, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.With three distinct streams, targeted towards academics, clinicians, and pharma-biotechs, tackling functional understanding, therapeutic development, and preventative approaches respectively, every single moment of your experience at the Congress will be tailored directly to you. We invite you to join us for 2 days of intense learning, mind-sharing and networking opportunities designed to encourage meaningful connections.Meet and learn from industry leadersConnect in person with the FDASecure funding from the NIHNetwork with top academics and clinicians in the field

Britain is in the midst of a productivity crisis. Analysis shows that output levels have barely risen since the last recession, and there is a long standing and now growing productivity gap between the UK and the likes of France and Germany. The Productivity Summit presents cross-industry case studies from UK businesses implementing productivity models and strategies, covering three main areas – systems and modelling, employee engagement and health and wellbeing. Living up to its name, The Productivity Summit offers an interactive and energetic programme intent on getting the most out of one day. Case studies from the UK’s leading brands include: How to measure productivityHow to actually implement flexible working and mental health programmes to drive productivityWhat a good productivity model looks likeHow to manage change internallyPractical steps to improve diversity and resulting impace on business productivityHow to improve non-financial compensation and benefits to compete for talentHow to prepare for Brexit and the impact it's going to have on productivityUsing internal champions to build productivity into company culture"I am currently exploring a number of ways to introduce further flexibility within our workplace...The Productivity Summit agenda is perfect for my areas of interest!" Andy Stoker, Director - Organisational Culture & Transformation, Cisco

CAR-T cell therapy has shown unparalleled success in haematological malignancies, paving the way for the field of immuno-oncology. In 2017 two therapies achieved FDA approval in the USA, and following recent approval by the EMA, it is a landmark time for the industry. Despite the huge successes there are still a number of hurdles to overcome before CAR-T can be effective in mainstream oncology beyond haematological malignancies. The European CAR-T Congress’ mission is to address the opportunities and challenges that presently face the CAR-T field, to maximise the potential of this ground-breaking therapy.Sessions include:Solid tumour targeting: overcoming the tumour microenvironmentMulti-specific & dual targeting CARsProcess development, scalability & automationAllogeneic vs Autologous: the potential of off-the-shelf therapiesPatient access, implementation & regulatory challengesAdvances in gene engineeringSafety and toxicity

The Phage Futures Congress will bring together peers from biotech companies and academia, along with experts from regulatory bodies, pharmaceutical companies and government institutions, to discuss how to actively progress clinical science and viable phage application routes to market. You will hear about:Regulatory guidance to achieve clinical data from Cara Fiore, FDAStrategies to access the market via the veterinary, personalized medicine and traditional pharmaceutical routesInsights into investment drivers for phage therapy from NIH and Boehringer IngelheimFacts on how to manufacture GMP phageApplications to overcome multi-drug resistance with combined approaches such as phage therapy and antibiotics "This congress has the potential to act as a catalyst to further cooperative and collaborative efforts to develop alternate Phage based approaches to the antibiotic crisis. In addition, the location in the Washington DC area will facilitate an opportunity for Government Agencies, responsible for public health, such as the NIH, FDA, USDA and DOD to participate and interact with educational research groups and biotechnology companies developing phage therapies and initiating clinical testing." - Carl Merril, Adaptive Phage Therapeutics

Data has gravity.It is well known that the network edge, in the Internet of Things, is where the critical mass of digital data resides, and where it is collected. Scalability bottlenecks to ubiquitous AI, such as power consumption, bandwidth, latency, connectivity and security have led to recent innovations in on-device processing and edge infrastructure such as micro-data centers and distributed computing architecture.The Edge Computing market will reach $34 billion by 2023, growing at 35% annually, unleashing a wave of services and applications at the network edge that can be optimized with artificial intelligence. As a recent explosion in hardware innovation provides the necessary compute to migrate diverse AI workloads to the Edge, a new generation of edge-native and edge-enhanced software applications is emerging.The Edge AI Summit will bring together 200+ key thought-leaders and industrial practitioners to discuss the challenges and opportunities of decentralized, distributed intelligence. Join us to examine use cases of edge-based artificial intelligence applications and explore this new computing paradigm that promises to accelerate and democratize AI adoption across the globe. This event is intended for Senior Director/VP-level attendees and above, and is a high-level networking and business development meeting, with content tracks focusing on both business and technology.

Personalised Nutrition Europe is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet, incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.Personalised Nutrition Europe draws on industry leaders who discuss how to integrate existing and new types of data around health and disease to reveal informative and actionable insights. The Summit will teach you how to better acquire, understand and use your data to forge the key partnerships in this industry. Key Takaways:How can I scale up my product?How can I measure the performance of my nutritional intervention?How can I better target the consumer by understanding motivation behind nutrition choices?How can I partner with retailers and industry leaders?How do I use my data to forge partnerships in industry?How can I target my consumer better and ensure they adhere to nutritional plans?How to identify and incorporate the best science into my business?How can I produce high quality data with low cost testing?How can I improve my business strategy to capitalise on growing interest in personalisation?What policy changes do I need to consider to protect my business?

The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.Join 100+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.Join 100+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.With an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

SKIN MICROBIOME IS SET TO REVOLUTIONISE DERMATOLOGYWith the European cosmetics industry playing a leading role in science-driven product development and innovation in skincare, we are proud to announce that we are bringing the Skin Microbiome Congress to London, following the success of our sold out inaugural event in Boston.As new clinical data transpires to support the role of the skin microbiome in common conditions from acne and eczema to dandruff and skin allergies, Pharmaceutical Researchers and Cosmetic Formulators alike are turning their attention to designing and testing products that contain live bacteria, bacterial extracts or prebiotic and postbiotic ingredients to manipulate the skins microbiota.The European Skin Microbiome Congress will bring together leaders from pharmaceutical, therapeutics and cosmetics industries, to showcase:• Cutting edge research• New therapeutic & cosmetic advances• Consumer trends & insights• Regulatory considerationsJoin 200+ industry leaders to explore the different pathways market and how to translate therapeutic research into commercially viable cosmetic products.View highlights from the inaugural SOLD OUT Skin Microbiome Congress, May 30-31, 2018Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.

Animal Health Innovation Asia is a premier B2B conference showcasing emerging Animal Health and Nutrition companies, from China and across Asia-Pacific, that are activity seeking financial investment or strategic partnership conversations with large corporate firms.Our plenary sessions provide guidance on veterinary market trends and animal health industry dynamics in China & A-PAC, insight on how emerging companies are using new innovations to prevent disease and market analysis on the M&A activity across the animal health and nutrition markets in Asia.

The AI Hardware Summit is the first and only conference dedicated solely to the ecosystem developing hardware accelerators for neural networks and computer vision.Join 250+ senior technology leaders from AI chip start-ups, semiconductor companies, system vendors/OEMs, data centers, end users, financial services, investors and fund managers, to build a comprehensive architectural roadmap of the emerging AI chip market.Take advantage of unique networking opportunities to meet key industry leaders 1-2-1, whilst also exploring: Innovations and Optimizations of High-Performance Chip Architectures: GPUs, ASICs & TPUs, FPGAs…Alternative Approaches: hybrid digital/analog computing, neuromorphics & neuromemristive systems, quantum computing.The Role of Software: assistance software, software frameworks, ecosystems, and applications. Generating user-friendly native code and linking open source machine learning frameworks like TensorFlow & Caffe.Industry Developments: Start-up & Corporate R&D, Venture Capital and Corporate Venture Capital investment trends, strategic acquisitions & partnerships.Forecasts predict that the AI (chipsets) market is expected to grow from USD 7.06 Billion in 2018 to USD 59.26 Billion by 2025, at a CAGR of 35.5% from 2018 to 2025 (Business Wire, 2018), the chip market is no longer standing still. As we approach a paradigm shift in computing, there is little doubt that a combination of the processing units currently in development will accelerate AI research and development, far beyond the capabilities of current platforms. There is need for sharing knowledge on the best way to turn this shift into an opportunity and roadmap the future ahead.

The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.View highlights from the inaugural Skin Microbiome Congress, May 30-31, 2018Join 200+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

Showcasing the Most Exciting Innovation in Farm Management, Nutrition and Health InnovationThe Aquaculture Innovation Summit is a new conference, as part of the Animal Health Innovation series, which focuses on showcasing and supporting innovation and sustainability initiatives in three key areas of aquaculture: farm management, nutrition and health.Our objective at this two-day event is to bring to light cutting-edge modern technologies and solutions that are helping shape one of the most important industries for the future of global protein. Below is a preview of some of the topics to be discussed:Innovation Showcase: The 12 most exciting innovations in aqua across farm management, nutrition and health, each seeking financial investment and strategic partnershipDigital Trends: How innovative companies are using digital and tech solutions to prevent diseaseTech & Productivity: What challenges are seafood producers currently facing and what technology can make an impact on productivity?Health and Nutrition Trends: Oral Vaccines, Medicated Feed Additives and Fish MicrobiomeGlobal Focus: Trends in the aquaculture markets in Latin America and Asia.Expanded focus on species: What are the opportunities for innovation in Tilapia and Shrimp?

Developing BioAg products brings with it various demands and challenges - for example complying with regulation, managing resistance, formulation compatibility of ingredients and scale up challenges.Agbio Innovate USA aims to address regulatory hurdles that directly impact the biopesticide and biostimulant sector in North America as well as explores formulation technology and R&D advances with insight from industry leaders.We also address the exciting rise of AgTech and the future of vertical farming.With application technology advancing, formulations and products need to adapt to meet the future needs of farmers and growers.Direct answers to your regulatory challenges with unparalleled guidance sessions on the EPA's regulatory requirements under FIFRA that are applicable to biopesticides and biostimulantsCreate BioAg commercialization opportunities by building R&D and investment partnerships - network with 80+ industry representatives including ABM, Bayer, BioConsortia, Marrone Bio Innovations and many more3Bar Biologics and Global BioAg Linkages share how to build an ecosystem where companies are working jointly together, each bringing their unique skill set to solve problems and create value- bringing you measurable results for success Accelerate BioAg product development by using advanced technologies – Discover insight from Terramera on how machine learning and artificial intelligence are being used to analyze and interpret data across multiple development platforms

The Personalized Nutrition Innovation Summit is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.5 key benefits of attending:• Enabling collaboration through dedicated networking sessions• Hear from the disruptors like Habit• Gain insight from major nutrition companies like Kellogg to understand their drivers• Understand from STYR Labs about making better babies through personalized nutrition and AI• Recognize the major consumer trends reshaping nutritionFeaturing breakthrough technologies, including:• Microbiome analytics• Genomics• Biomarkers• Biosensors & wearables• AI & Big data• Retail & eCommerce

The Global Probiotics in Animal Feed Market is poised to grow at a CAGR of around 7.9% over the next decade to reach approximately $6.37 billion by 2025.The European Animal Microbiome Congress brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, animal pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to showcase the latest commercially viable research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering. Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. This conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts.

Join the first ever conference series connecting human biotechs with the animal health industry.
Following the event's hugely successful launch in Boston, USA, Human Biotech & Animal Health Business Partnering Summit is now coming to Europe.
Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.

The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.Join 250+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!

Animal Health Innovation Latin America returns for 2018, as an extension of our already successful series in Europe and Asia. This event brings early & mid stage biotech companies together with financial investors and pharmaceutical companies to better stimulate the growth of the animal health industry and the speed of innovation through partnerships and investment. The Forum combines efficient 1-on-1 meetings with educational content, pitching sessions and high-level keynote talks from global leaders. We have live translation of all sessions in English and Portuguese.

The global agrochemical market is projected to reach $266.0 billion by 2021, by attending the AgChem and Technology Congress you will gain the knowledge to develop your products and reach your share in this market. Learn from key agrochemical companies as well as leading academics, about how they are working to produce more effective crop protection products, including challenges they have faced with their new formulations and application technologies and strategies they used to overcome these challenges.With meeting time available during the networking breaks to facilitate new collaborations, this congress will provide you with all that you need to develop innovative products and be at the forefront of the future of crop protection.

The Microbiome Invest Congress 2018 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.

The influence of the microbiome on human health & disease has been a growing area of interest in recent years, however until recently the impact of the microbiome on the initiation, progression & treatment of cancer was unknown. In recent months research has uncovered the potential of the microbiome to improve cancer therapies and to be a useful tool for patient stratification and diagnostics. With a better understanding of the oncobiome there is the potential to improve patient outcomes and increase the efficacy of existing therapies and drugs.

Planning for the future - join 100+ strategy experts from agrochemical, biostimulant, biopesticide, AgTech and investment industries to discover the changing needs of these markets and how to execute a corporate strategy that works.

From concept to vision - join 100+ experts from the BioAg industry to hear how you can overcome the key challenges within these growing markets and maximise the new opportunities plant health and biocontrol present.

The Animal Microbiome Congress USA brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to understand the latest research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering.Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. The conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts. Our ‘MEETING MOJO’ platform will allow you to schedule meetings across the two conference days to facilitate future collaborations and business partnering.

The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.

Join the first ever conference connecting human biotechs with the animal health industry.
Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.

The Artificial Intelligence: Transforming Pharma Congress will discuss AI's potential for more efficiently discovering medical trends and efficacious therapeutics and also for streamlining the development phase. We'll be sharing case studies and analysis into current AI partnerships and collaborations.

Welcome to the 3rd Annual North America Microbiome Congress!The 3rd Annual North America Microbiome Congress in San Diego, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.With a focus on 5 microbiome niches such as the gut, lung, oral, skin and vaginal- we invite you to join us for 3 days of intense learning, mind-sharing and networking opportunities designed to encourage meaningful connections. In addition, we will be hosting poster sessions for PhD students to provide opportunities for all scientists to learn about state-of-the-art research methods and clinical protocols for conducting microbiome work.Meet and learn from industry leadersConsider the practical aspects of promoting effective partnershipsLearn from the latest unpublished dataNetwork with top academics and clinicians in the field

CAR-T clinical trials have demonstrated unparalleled success achieving remission rates of up to 94% in multiple hematological malignancies…is CAR-T therapy what we’ve been waiting for?Join 18+ thought-leaders from biotech, big pharma, academia and the wider service community on 30th – 31st January 2018 at Europe’s first congress dedicated to addressing the challenges and opportunities of CAR-T therapies.Hear first-hand results from unpublished human and clinical studiesExplore the challenges of the tumour microenvironmentUnderstand how to implement a combined approach to cell therapyDiscover safety switch improvement strategiesNetwork with 100+ attendees to share knowledge and understand the commercial opportunities of CAR-TWith a 50:50 split of academia to industry, build relationships whilst being updated by 20+ amazing speakers from University Hospital of Cologne, Catapult, Cellectis and more on all of the latest developments in this exciting field. Get involved today.

The 3D Cell Models Congress 2018 will present the latest developments and innovation in three-dimensional cell models including organoids, spheroids, and organ-on-a-chip, as well as bioprinting technologies.

RPA & Cognitive Congress Dallas is assembling leading service delivery and automation professionals for frank and pragmatic discussion about RPA, the benefits and opportunities of this technology, and the real-world challenges they’re facing in implementation.

The RPA and Cognitive Congress is India’s first deep-dive RPA and Cognitive automation conference. This event follows on from two successful events earlier this year in London and Orlando, attracting 120+ leading executives in service delivery.

The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.

Demand for innovative products in agriculture is increasing, R&D of AgriProducts will equip you with the knowledge needed to succeed in this market. Meet over 100 senior-level executives and influencers from the agrochemical and biological industries.Explore early stage research and discovery into agrochemical and agbio products.

Health, Wellness & Money is THE destination for the hottest early to mid-stage OTC health and wellness companies and healthtech innovators to connect with Strategic and Financial Buyers looking to build even more enterprise value with their next acquisition or investment.Every attendee, via the MEETING MOJO platform, will be able to schedule 12+ One-to-One private meetings to ensure the right connections are made.Why Consumer Health & Wellness? $3.4 TRILLION GLOBAL WELLNESS MARKET IS NOW THREE TIMES LARGER THAN WORLDWIDE PHARMACEUTICAL INDUSTRY. Global Wellness Institute StudyWellness sectors seeing the most significant growth since 2010 are:Healthy eating, nutrition and weight loss (108 percent increase to $276.5 billion)Preventative and personalized health (78 percent increase to $243 billion)Complementary and alternative medicine (65 percent increase to $113 billion)

The Animal Microbiome Congress is a place for veterinary researchers, animal breeders and producers, feed and strain manufacturers, pharmaceutical and nutrition companies, government and regulatory bodies and ground-breaking solution providers to discuss ideas, form collaborations and identify strategies for development to manipulate the animal microbiome.

Animal Health Innovation Asia is the premier B2B conference showcasing innovative technologies within the livestock, aquaculture and companion animal health markets. Last year, over 160 senior-level executives and influencers joined us to engage with the industry and discuss financial investment, M&A and market access into Asia. Our 2017 event in Beijing had a special focus on China, with ten strategic partners from the region forming our Company Showcase - a chance for global companies to find new business partners from within China.

With the increase in the number of cell and gene therapies being developed and coming to market globally and the potential to revolutionise the treatment of disease, this summit will discuss strategies for pricing and contracting cell or gene therapies that will allow payers to fund these innovative and significantly beneficial therapies to result in rapid patient access.

The Nordic Robotic Process Automation & Cognitive Congress will examine RPA’s transformational impact as a digital tool for back office processing. The content of our two-day congress details case studies from leading organizations globally and addresses how these businesses have effectively utilized RPA as a means to improve service delivery, enhance productivity and reduce costs.

From momentous transactions such as Estée Lauder’s acquisition of Too Faced, to a spell of minority investments in early-stage companies such as L Catterton’s investments in Kopari Beauty, VMG’s investment in Drunk Elephant and Main Post Partners’ investment in Milk Makeup, M&A activity in the beauty industry is thriving.

The Aquaculture Innovation Summit is a new conference, as part of the Animal Health Innovation series, which focuses on showcasing and supporting innovation and sustainability initiatives in three key areas of aquaculture: farm management, nutrition and health.

What People are Saying

The eSports Conference so far is the only conference that has been able to bring together all the influencers and intelligence of the industry in one location. It’s been truly an opportunity to get informed and get connected.

Wouter Sleijffers, FNATIC

The event was an open forum to share information, best practice and learnings on the RPA journey. Presentations were relevant, informative and thought provoking. Vendor input was focussed on what to think about regarding ambition and strategy – not favoring a particular technology.

Siobhan Walsh, Coca-Cola

Hearing from business users the challenges they faced, processes they put in place and benefits RPA brings was very useful. It really helped us in determining our strategy for RPA implementation and highlighted the items we need to pick up with high priority.

Boudewijn de Langen, NNIP

Fantastic opportunity to learn from practioners and experts in the field, both through the formal sessions and networking time.

Keri Smith, Syngenta

It’s a unique forum to bring people together from different parts of the value chain in animal health – from small companies to large companies.

It’s a great place, you will make tons of great contacts; and if you’re not here you’re missing out!

Randolph Seidler, VP, Global Head of Business Development, Boehringer Ingelheim

Just come along to one of these events and you’ll be hooked and definitely want to visit more of them – especially once you have a chance to meet everybody here and engage with the industry!

Oliver Hardcastle, Junior Partner, Stonehaven Consulting

The whole conference proved to be very useful to me as a game developer, especially the parts covering the various legal issues that exist now or might have an impact in the future.

Todor Karaivanov CRYTEK

What would I say to people that are not at this event? Shame on you - everybody else is!

Clint Lewis, EVP, President of International Operations, Zoetis

I greatly enjoyed meeting and networking with other esports professionals and sharing ideas on where this new industry is going.

Steve Fowler, ARENANET

Really good to hear customer stories from different stages in the journey. Also, the 3 main vendors represented were extremely professional in how they addressed the challenges and opportunities.

Niall Cunnane, AIB

I enjoyed meeting with both industry insiders and newcomers, feeling we’re actually shaping the future of eSports.

Lam Hua, OXENT

Companies that haven’t come to the event yet need to realise that it’s an investment and it will really broaden their horizons. This is a group of people that have been in the industry along time, and also a group of new people that are just starting out, and if they’re not here for that conversation they’re really missing that the breadth that I just don’t think they can get anywhere else. This is a really unique opportunity for them!

Linda Rhodes, Independent Animal Health Consultant

Great range and openness of the speakers from other companies.

Adam Bilson, Direct Line

The event was very useful especially for networking, alongside that to hear more about the legal aspects and the regulations in regards to gambling was also amazing information to learn.

Adam David, KINGUIN

Excellent atmosphere and good practical examples.

Teemu Vieruaho, PWC Finland

The best thing about the event is the opportunity to network with people that, if we were to have to go visit as a company, we’d have to travel the world to meet – but they’re all congregated here so we have a good op to visit with them and exchange ideas and to collaborate with them.

Johnny Jacobsen, Global Head of Customer Experience, Argenta Limited

It has been an exciting event. It’s an interesting piece bring together different kinds of companies – big pharma, start-up companies and even, now, technology companies, like Antelliq, that are representing big data and the high-tech touch, so it’s an excellent convergence form all these types of companies.

Stefan Weiskopf, CEO, Antelliq

The event has been great, we’ve had the opportunity to meet a few people that we wouldn't ususally meet, and also to meet again with colleagues and clients we’ve been working with before, so it’s a great opportunity to be exposed as an organisation, but also to network and collaborate with different industries and different clients from within the industry. I think it’s been fantastic!

German Graff, BioResearch Business Development Manager, IDEXX BioResearch

The event really brought together a very valuable and diversity collection of players in the eSports space. The viewpoints expressed were very insightful and helped to really represent the full richness of activity and interests in the ecosystem.

Cliff Mercer, JIST.TV

The European eSports Conference was an amazing event. The variety of topics and speakers provided a great overview of the current issues of our industry and suggested ways of how to move forward and continue our growth. It was great to meet the many industry insiders as well as specialists from adjacent industries like games publishing, betting and event venues, to network and discuss potential collaborations. I’m very much looking forward to the next edition.

David Hiltscher, ESL GAMING

The tools and resources your team provided were invaluable to personal and career growth. Not only from a networking perspective, but it really felt like a higher learning seminar covering fascinating material.

Oscar Miranda, WARGAMING.NET

The event has been great. I really enjoyed the pre-conference workshops, and after that it just got better. We’ve had great interactions with the industry, and it’s really been a lot of fun!

Jeroen Kortekaas, CSO, BunyaVax

There was a wide cross section of attendees and presenters from all facets of the eSports Industry plus many other companies attending who were looking to get involved. The variety of presentations and topics made sure that there was always something of interest being discussed.

David Yarnton, GFINITY

The case studies were great as they helped me visualise taking the concept through to practical application at scale

Andrew Shapcott, Lloyds Banking

I think this is the best place to be presenting because this is the animal health event. It has been a really excellent meeting!

We need some information to know how best to respond to your request below.

Email *

First Name *

Last Name *

Company *

Permission

Yes, I would like to receive news and information from Kisaco Events.

Topics Interested In *

Message

s79kkfi3w1 To prevent automated spam submissions leave this field empty.

Leave this field blank

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

About Us

MEET

industry peers that will help build a career-changing network for life.

LEARN

from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

NOTE

down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

INVEST

both in your company growth and your own personal development by signing up to one of our events and get started.

About Kisaco Research

Kisaco Research works with the early adopters and leaders of growth markets in driving their respective industries forward and in providing the right knowledge, learning and social opportunities to stimulate business growth quickly and effectively.

Kisaco Research produces, designs and hosts B2B industry conferences and exhibitions. Our platforms are neutral, so that our attendees get the right information from the most relevant people.

Our level of research ensures the topics and products we offer are of utmost relevance and timeliness; our 30+ years of combined experience in the event industry means we have an unmatched level of strategic social engineering onsite.

Join our conferences to ensure you benefit from the high-quality knowledge, learning and networking opportunities. Find out more about our upcoming events by emailing [email protected].